Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00169_DB00364_nanopub.RAYFArTgXeSZ_2dUTq8KjrEO24aFZ3BpneHiOBCm_mI2Q#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00169_DB00364 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00169_DB00364 label "DDI between Cholecalciferol and Sucralfate - Vitamin D analogs such as cholecalciferol may increase the serum concentration of sucralfate. Specifically, the absorption of aluminum from sucralfate may be increased, leading to an increase in the serum aluminum concentration. Avoid chronic and/or excessive use of aluminum and aluminum-containing products (such as sucralfate) in patients who are also taking vitamin D analogs. Any patients consuming such a combination should be monitored closely for aluminum status and signs/symptoms of aluminum-related toxicities. [drugbank_resource:DB00169_DB00364]" assertion.
- drugbank_resource:DB00169_DB00364 identifier "drugbank_resource:DB00169_DB00364" assertion.
- drugbank_resource:DB00169_DB00364 title "DDI between Cholecalciferol and Sucralfate - Vitamin D analogs such as cholecalciferol may increase the serum concentration of sucralfate. Specifically, the absorption of aluminum from sucralfate may be increased, leading to an increase in the serum aluminum concentration. Avoid chronic and/or excessive use of aluminum and aluminum-containing products (such as sucralfate) in patients who are also taking vitamin D analogs. Any patients consuming such a combination should be monitored closely for aluminum status and signs/symptoms of aluminum-related toxicities." assertion.
- drugbank:DB00364 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00169_DB00364 assertion.
- drugbank:DB00169 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00169_DB00364 assertion.